- Home
- STRO vs ZTR Comparison
STRO vs ZTR Comparison
Compare STRO & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | ZTR |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | 133 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 381.1M | 342.5M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | STRO | ZTR |
|---|---|---|
| Price | $22.94 | $6.84 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.33 | N/A |
| AVG Volume (30 Days) | ★ 441.4K | 218.5K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $6.14 |
| 52 Week High | $43.85 | $7.11 |
Technical Indicators
Market Signals| Indicator | STRO | ZTR |
|---|---|---|
| Relative Strength Index (RSI) | 34.27 | 54.57 |
| Support Level | $19.11 | $6.68 |
| Resistance Level | $27.96 | $6.93 |
| Average True Range (ATR) | 2.14 | 0.07 |
| MACD | -0.55 | -0.00 |
| Stochastic Oscillator | 10.83 | 56.67 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.